cytarabine has been researched along with Adenopathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
André, M; Beel, K; Bonnet, C; Boulet, D; Caron, C; De Samblanx, H; Debussche, S; Delrieu, V; Jacquy, C; Janssens, A; Lemmens, J; Madoe, V; Maerevoet, M; Maertens, V; Meers, S; Pranger, D; Schauvlieghe, L; Schroyens, W; Van Den Broeck, I; Van Den Neste, E; Van Eygen, K; Van Hende, V; Van Hoof, A; Vanstraelen, G; Vergote, V; Verhoef, G | 1 |
1 other study(ies) available for cytarabine and Adenopathy
Article | Year |
---|---|
Results from the Belgian mantle cell lymphoma registry.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Belgium; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Hepatomegaly; Humans; Lymphadenopathy; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Staging; Registries; Retrospective Studies; Rituximab; Splenomegaly; Transplantation, Autologous; Young Adult | 2017 |